Evidence map›Paper›PMID 36148819›Full record

ArticleEuropean journal of neurology2023

Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases.

Pilar M Ferraro, Ester Gervino, Emiliano De Maria, Giuseppe Meo, Marta Ponzano, Matteo Pardini, Alessio Signori, Angelo Schenone, Luca Roccatagliata, Claudia Caponnetto

Open access · hybridAbstract read
In one paragraph

Article in European journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  5. The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Pilar M FerraroNeuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0002-5008-2791
Ester GervinoNeuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Emiliano De MariaNeuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giuseppe MeoNeurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Marta PonzanoDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.ORCID 0000-0003-4091-4686
Matteo PardiniNeurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0002-4740-1982
Alessio SignoriDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.ORCID 0000-0001-6289-9144
Angelo SchenoneNeurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Luca RoccatagliataNeuroradiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0001-8029-3947
Claudia CaponnettoNeurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.ORCID 0000-0002-5547-3900
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeMild behavioral impairment (MBI) has been increasingly regarded as the neurobehavioral axis of predementia risk states, but a specific investigation of its detection as a potential marker of prodromal dementia in motor neuron diseases (MNDs) is still lacking. The aims of our study were therefore to explore MBI in MNDs both at onset and over the disease course, and to evaluate its relationship with baseline and longitudinal cognitive features.

methodsSixty MND patients with cognitive/behavioral, mood, and motor examinations were recruited and followed longitudinally for up to 15 months. Associations between baseline MBI symptoms and clinical features were tested using the Spearman correlation coefficient. Based on longitudinal data, relative deltas of variation for each cognitive measure were generated, and linear regression models were then used to evaluate the role of baseline MBI symptoms in predicting longitudinal rates of cognitive decline.

resultsAt disease onset, the most impaired MBI domain was affective/emotional dysregulation, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms correlated with more severe baseline motor, cognitive/behavioral, and mood disturbances (p values from <0.001 to 0.05). Longitudinally, the greatest decline was observed in the affective/emotional dysregulation domain, followed by impulse dyscontrol, apathy, and social inappropriateness. Greater MBI symptoms at onset were significant predictors of more severe longitudinal cognitive decline in both amyotrophic lateral sclerosis (ALS)-specific and ALS-nonspecific functions (p values from <0.001 to 0.03).

conclusionsMBI represents a valuable clinical marker of incident cognitive decline in MNDs, and its evaluation has good potential for detecting dementia in its preclinical/prodromal phase.

Indexed as

Amyotrophic Lateral SclerosisCognitive DysfunctionDementiaMotor Neuron DiseaseHumansNeuropsychological Testsamyotrophic lateral sclerosislongitudinal cognitive declinemild behavioral impairmentmotor neuron diseasesprodromal dementia

Identifiers

PMID36148819
PMCPMC10091712
OpenAlexW4296796335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.